about
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNOverview of C3 GlomerulopathyComplement in disease: a defence system turning offensiveCharacterization of C3 in C3 glomerulopathy.Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits.Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor.Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN.C3 glomerulopathy and current dilemmas.Protracted Clinical Course of Postinfectious Glomerulonephritis in a Previously Healthy Child.Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions.Leishmaniasis-Associated Membranoproliferative Glomerulonephritis With Massive Complement Deposition.Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy.Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.Precision Transplant Medicine: Biomarkers to the Rescue.C3 glomerulonephritis with a severe crescentic phenotype.Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.C3 Glomerulopathy.C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction.
P2860
Q26741542-4AE5B037-7829-4050-A3DD-48AA58760C78Q26747262-32A8B5CD-D5B5-48C0-8471-C225E50A4883Q33432423-1B0A089A-8275-4695-9438-24602D6040F4Q36099921-E7F8989D-5F27-4C64-8F6E-753F091254E7Q36394063-624B020F-C573-4A74-98A5-FF38216174F4Q37285007-4850FDD8-3468-40EA-8FE5-52F5723E797DQ38749694-594ACF93-3BE7-4C0A-BB2D-D9479411A9C6Q39016179-860BAE0A-134C-4C4F-822B-F7A03C8994A8Q40439038-000AB240-C8C6-4BC6-92FB-B622D77288CCQ40658779-A56F0E87-D665-42B4-A709-E76064D52497Q41613369-B2D4B538-90F6-438D-B8F6-86F0F42734C5Q46098332-86F7A5BC-EB3D-4294-8203-3725D987B7BEQ47428540-AC430E11-FD23-45FD-97C7-9F1A3B1EF7F2Q47650832-64876C64-8DDF-4EF0-A4C9-615BAE2450ADQ47656083-5DB35AE9-685B-4CFC-975E-54454C3F3A60Q48309420-6E1CCB5C-F760-4458-ADB4-AC728D17B462Q49497379-D1756061-B1D2-43F2-AEEF-C8C13595FE9FQ51730313-D41AE961-84EF-444E-A87A-9CF434C09107Q52876323-1FA53A4F-3DB3-491B-A3F9-F1EFB33E1472Q55287167-13669A1E-B2D7-4FC0-8122-3F9B529C2228
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Histopathology of MPGN and C3 glomerulopathies.
@en
type
label
Histopathology of MPGN and C3 glomerulopathies.
@en
prefLabel
Histopathology of MPGN and C3 glomerulopathies.
@en
P2860
P356
P1476
Histopathology of MPGN and C3 glomerulopathies.
@en
P2093
H Terence Cook
Matthew C Pickering
P2860
P2888
P356
10.1038/NRNEPH.2014.217
P407
P577
2014-12-02T00:00:00Z